2026 Volume 52 - Canada Communicable Disease Report (CCDR)
Submit a manuscript
About CCDR
Browse
ISSN: 1481-8531
2026 Volume 52
CCDR: Volume 52-3, March 2026: Vaccine Safety: Uptake and Hesitancy
- Canada’s National Advisory Committee on Immunization (NACI) in 2025: Celebrating 60 years of service, a decade of change, and a dynamic future ahead
- Vaccine uptake and hesitancy among Black people people: A scoping review
- Promoting influenza vaccination among health professionals in Canada: Results of an online survey on Facebook
- What do parents of school-aged children want to know about HPV vaccination in Canada? Results of an online survey on Facebook
- Tracking Canada’s 2015 vaccine research and development priorities: Where are we a decade later?
- Vector-borne Disease Surveillance in Canada, 2024
CCDR Volume 52-1/2, January/February 2026: Tick and Mosquito Surveillance in Canada
- Summary of the National Advisory Committee on Immunization (NACI) Statement: Updated recommendations on herpes zoster vaccination for adults who are immunocompromised
- Isolation of toxigenic Corynebacterium diphtheriae from cutaneous lesions in a donkey in Ontario, Canada, 2024: Implications for zoonotic disease transmission and One Health approach
- Vector-borne Disease Surveillance in Canada, 2023
- Surveillance for Ixodes scapularis and Ixodes pacificus ticks and their associated pathogens in Canada, 2021
- Surveillance for Ixodes scapularis and Ixodes pacificus ticks and their associated pathogens in Canada, 2022
- Invasive pneumococcal disease surveillance in Canada, 2023
- Changing case definition: An analysis of its impact on Lyme disease surveillance in Nova Scotia